PubMed:17095532 / 1192-1557 JSONTXT

{"project":"uniprot-mouse","denotations":[{"id":"T6","span":{"begin":110,"end":113},"obj":"http://www.uniprot.org/uniprot/P49025"},{"id":"T7","span":{"begin":291,"end":294},"obj":"http://www.uniprot.org/uniprot/P49025"}],"text":"Owing to the presumed requirement for multivalency for in vivo allergenicity, our molecular data showing that Cit s 1 is monovalent as regards glycosylation and that the single N-glycan is the target of the IgE response to this protein explain the immunological cross-reactive properties of Cit s 1 as well as its equivocal nature as a clinically relevant allergen."}

{"project":"GO-BP","denotations":[{"id":"T4","span":{"begin":143,"end":156},"obj":"http://purl.obolibrary.org/obo/GO_0070085"}],"text":"Owing to the presumed requirement for multivalency for in vivo allergenicity, our molecular data showing that Cit s 1 is monovalent as regards glycosylation and that the single N-glycan is the target of the IgE response to this protein explain the immunological cross-reactive properties of Cit s 1 as well as its equivocal nature as a clinically relevant allergen."}

{"project":"sentences","denotations":[{"id":"TextSentencer_T8","span":{"begin":0,"end":365},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":365},"obj":"Sentence"},{"id":"T8","span":{"begin":0,"end":365},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Owing to the presumed requirement for multivalency for in vivo allergenicity, our molecular data showing that Cit s 1 is monovalent as regards glycosylation and that the single N-glycan is the target of the IgE response to this protein explain the immunological cross-reactive properties of Cit s 1 as well as its equivocal nature as a clinically relevant allergen."}

{"project":"GlycoBiology-Motifs","denotations":[{"id":"T2","span":{"begin":177,"end":185},"obj":"http://rdf.glycoinfo.org/glycan/G00027MO"}],"text":"Owing to the presumed requirement for multivalency for in vivo allergenicity, our molecular data showing that Cit s 1 is monovalent as regards glycosylation and that the single N-glycan is the target of the IgE response to this protein explain the immunological cross-reactive properties of Cit s 1 as well as its equivocal nature as a clinically relevant allergen."}